Significantly, tumor tissues derived from UMUC-3/shScr xenografts showed reduced expression of the epithelial marker E-cadherin and enhanced levels of the mesenchimal protein vimentin compared to UMUC-3/shPGRN orthotopic xenografts. The gene discussed is VIM; the disease is neoplasm.